3 assets in Intraepithelial Neoplasia

Therapeutic assets addressing Intraepithelial Neoplasia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fluorouracilum Intraepithelial Neoplasia	Rutgers, The State University of New Jersey	P4	BB (69)
Capecitabine Intraepithelial Neoplasia	Rutgers, The State University of New Jersey	P4	BB (64)
9-valent human papillomavirus recombinant vaccine Intraepithelial Neoplasia	Xiamen University	P3	B (60)